The freely diffusible and moderately reactive free radical, nitric oxide (NO), 2 is a biological signal molecule in numerous physiological and pathophysiological processes (for reviews, see Refs. 1-4). Nitric-oxide synthases (NOSs) catalyze the NADPH-dependent conversion of L-arginine to NO and L-citrulline (for reviews, see Refs. 5-7). In mammals, three different isoforms have been identified. Neuronal NOS (nNOS) and endothelial NOS (eNOS) are constitutively expressed, and their activities are Ca 2ϩ /CaM-dependent, whereas the inducible NOS (iNOS) is independent of intracellular Ca 2ϩ concentration. These isoforms share ϳ55% sequence identity yet differ in their size, tissue distribution, and regulation. The 165-kDa nNOS is located in neurons in the brain and neuromuscular junctions and is involved in neurotransmission. eNOS has a molecular mass of 133 kDa, is located in vascular endothelial cells, and is involved in vascular homeostasis. iNOS can be found in macrophages and many other tissues, has a molecular mass of 130 kDa, and is expressed only in response to endotoxins or inflammatory cytokines.All three isoforms of NOS are modular, homodimeric hemoflavoproteins. The N-terminal half of each NOS isozyme is similar to the cytochrome P450 enzyme family and contains iron protoporphyrin IX (heme). It is referred to as the heme domain or the oxygenase domain. This latter domain also contains tetrahydrobiopterin-and arginine-binding sites. The C-terminal half of each isozyme is the flavin-binding domain (or reductase domain) and contains FAD-, FMN-, and NADPH-binding sites, much the same as in NADPH-cytochrome P450 oxidoreductase (CYPOR). These two domains are linked by a CaM-binding region (8). The constitutive isoforms (nNOS and eNOS) are Ca 2ϩ -dependent due to their reversible binding of CaM, providing a mechanism for rapid response in a signaling cascade. On the other hand, iNOS has tightly bound Ca 2ϩ /CaM and is virtually independent of Ca 2ϩ concentration (9). In contrast to the other NOS isozymes, it is regulated at the transcriptional level. As in the case of the P450 (CYP)-CYPOR system, the FAD in the reductase domain accepts a pair of electrons in the form of a hydride ion from NADPH and transfers them one at a time to FMN. FMN, in turn, transfers the electrons again one by one to the heme of the other monomer in the NOS dimer (10 -12). However, the mechanisms of electron transfer and regulation of the FMN domain interactions with its electron acceptor (the heme domain) in NOS and related enzymes, including CYPOR and methionine synthase reductase, are largely unknown. Only recently, studies on this subject have been emerging (13)(14)(15)(16).CaM regulates a wide range of cellular functions through its reversible Ca 2ϩ -dependent binding to target proteins, including NOS. CaM regulates NOS activity by controlling the rates of electron transfer between the two flavin cofactors and between * This work was supported, in whole or in part, by National Institutes of Health Grant GM52682 (to J. J. K.